1. Zhang M, Zheng X, Zhang X, Zhang Z, Wang X, Hu X*.Reproducible porcine model for kidney allotransplantation of low weight miniature pig.Transl Androl Urol.2022.11(4).439-450.SCI |
2. Fan B, Wang Y, Zheng X, Zhang X, Zhang Z, Hu X*.A Novel Angiogenesis-Related Gene Signature to Predict Biochemical Recurrence of Patients with Prostate Cancer following Radical Therapy.J Oncol.2022.2022: 2448428.2022: 2448428..SCI |
3. Xu Y, Zhang H, Zhang D, Wang Y, Wang Y, Wang W, Hu X*.Identification of a novel peripheral blood signature diagnosing subclinical acute rejection after renal transplantation.Transl Androl Urol.2022.11(10).1399-1409.SCI |
4. Zhang H, Zhang D, Hu X*.A Potential Fatty Acid Metabolism-Related Gene Signature for Prognosis in Clear Cell Renal Cell Carcinoma.Cancers.2022.14(19).4943.SCI |
5. Xue W, Huang Z, Zhang Y*, Hu X*.Patient, kidney, and pancreas survival in pancreas after kidney transplantation versus simultaneous pancreas and kidney transplantation: meta-analysis.BJS Open.2022.6(5).zrac108.SCI |
6. Wang Y, Zhang H, Hu X*.Characterization of Epithelial-Mesenchymal Transition Identifies a Gene Signature for Predicting Clinical Outcomes and Therapeutic Responses in Bladder Cancer.Dis Markers.2022.2022:9593039.2022:9593039.SCI |
7. Wang Y, Wang Y, Zhang D, Zhang H, Wang W, Hu X*.Identifying RBBP7 as a Promising Diagnostic Biomarker for BK Virus-Associated Nephropathy. J Immunol Res.2022.2022:6934744.2022:6934744.SCI |
8. Zhang X, Zhang Y, Zhao L, Wang J, Li J, Wang X, Zhang M, Hu X*.Exploitation of tumor antigens and construction of immune subtype classifier for mRNA vaccine development in bladder cancer.Front Immunol.2022.13.1014638.SCI |
9. Zhang D, Ye Y, Hu X*.A non-invasive piTreg-related gene signature for spontaneous tolerance in renal transplantation.GENE.2022.848.146901.SCI |
10. shuai Li#, Di Zhang#, Song Zeng, Tianjun Wu, Yicun Wang, He Zhang, Biao Wang*, Xiaopeng Hu*.Prognostic Value of Preoperative Albumin-to-Fibrinogen Ratio in Patients with Bladder Cancer. J Cancer.2021.12(19).5864-5873.SCI |
11. Qiao P#, Zhang D#, Zeng S, Wang Y, Wang B, Hu X*.Using machine learning method to identify MYLK as a novel marker to predict biochemical recurrence in prostate cancer.Biomark Med.2021.15(1).29-41.SCI |
12. Zhang D#, Wang Y#, Zeng S, Zhang M, Zhang X, Wang Y, Zhang Z, Wang X*, Hu X*.Integrated Analysis of Prognostic Genes Associated With Ischemia-Reperfusion Injury in Renal Transplantation. Front Immunol.2021.12.747020.SCI |
13. Xue W#, Zhang Y, Wang H, Zhang Y*, Hu X*.Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma. Front Immunol.2021.12.778746.SCI |
14. Zhang M#, Zhang X#, Yu M, Zhang W, Zhang D, Zeng S, Wang X*, Hu X*.A Novel Ferroptosis-Related Gene Model for Overall Survival Predictions of Bladder Urothelial Carcinoma Patients.Front Oncol.2021.11.698856.SCI |
15. Zheng X#, Li M#, Wang P, Li X, Zhang Q, Zeng S, Jiang T*, Hu X*.Assessment of chronic allograft injury in renal transplantation using diffusional kurtosis imaging.BMC Med Imaging.2021.21(1).63.SCI |
16. Wang Y#, Zhang D#, Hu X*.A Three-Gene Peripheral Blood Potential Diagnosis Signature for Acute Rejection in Renal Transplantation.Front Mol Biosci.2021.8.661661.SCI |
17. 1. Jiao W, Zhang Z, Xu Y, Gong L, Zhang W, Tang H, Zeng S, Zhang Q, Sun Z, Liu L, Hu X*.Butyric acid normalizes hyperglycemia caused by the tacrolimus-induced gut microbiota.Am J Transplant.2020.20(9)).2413-2424.SCI |
18. Zhang D, Zeng S, Hu X*.Identification of a three‑long noncoding RNA prognostic model involved competitive endogenous RNA in kidney renal clear cell carcinoma.Cancer Cell International.2020.20(1)).319.SCI |
19. Zhang D, Wang Y, Hu X*.Identification and comprehensive validation of a DNA methylation-driven gene-based prognostic model for clear cell renal cell carcinoma.DNA AND Cell Biology.2020.39(10).1799-1812.SCI |
20. Q Zhang#, Z Yu#, S Zeng, Lu L, Y Xu, Z Zhang, X Zhang, T Jiang*,X Hu*.Use of Intravoxel Incoherent Motion Imaging to Monitor a Rat Kidney Chronic Allograft Damage Model.BMC Nephrology.2019.20(1).1-10.SCI |
21. Zheng X#, Gong L#, Xue W, Zeng S, Xu Y, Zhang Y, Hu X*. Kidney transplant outcomes in HIV-positive patients: a systematic review and meta-analysis.AIDS Research and Therapy.2019.16(1).1-32.SCI |
22. Tang H#, Xu Y#, Zhang Z, Zeng S, Dong W, Jiao W, Hu X*.SDF 1/CXCR4 induces epithelial mesenchymal transition through activation of the Wnt/β catenin signaling pathway in rat chronic allograft nephropathy.Molecular Medicine Reports.2019.19(5).3696-3706.SCI |
23. Zeng S, Liang L, Zhang Q, Xu Y, Tang H, Zhang Z, Zhang X, Jiang T, Hu X*.Using functional magnetic resonance imaging to evaluate an acute allograft rejection model in rats.Magn Reson Imaging.2019.58(1).24-31.SCI |
24. Zhang Z, Liu L, Tang H, Jiao W, Zeng S, Xu Y, Zhang Q, Sun Z, Mukherjee A, Zhang X, Hu X*.Immunosuppressive effect of the gut microbiome altered by high-dose tacrolimus in mice.Am J Transplant.2018.18(7).1646-1656.SCI |
25. 陈云霞, 谷丽, 胡小鹏*.肾移植后反复泌尿系统感染的临床特征和病原学特点.中华器官移植杂志.2018.39(10).586-591.核心期刊 |
26. 曾嵩,王伟,张小东,胡小鹏*.肾移植后受者膀胱输尿管反流的诊治进展.中华器官移植杂志.2017.38(7).439-442.核心期刊 |
27. Xu Y, Zeng S, Zhang Q, Zhang Z, Hu X*.Stem Cell Mobilizers: Novel Therapeutics for Acute Kidney Injury.Curr Protein Pept Sci.2017.18(12).1195-1199.SCI |
28. Xue W, Zhang Z, Zeng S, Xu Y, Zhang Q, Wang W, Zhang Y, Zhang X, Hu X*.Expression and Clinical Significance of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and a Disintegrin and Metalloproteinase with Thrombospondin Type 1 Motif1 (ADAMTS1) in Post-Kidney-Transplant Bladder Tumors.Annals of Transplantation.2017.22.622-630.SCI |
29. 唐浩,徐岳,曾嵩,张子健,焦文娇,任亮,王伟,张小东,胡小鹏*.SDF-1/CXCR4信号通路在大鼠移植肾慢性排斥反应中的作用及其机制研究.中华器官移植杂志.2017.38(6).365-371.核心期刊 |
30. 张子健,胡小鹏*. ABO血型不合肾移植的现状及研究进展.实用器官移植电子杂志.2017.5(02).142-146.核心期刊 |
31. 胡小鹏,田野,朱同玉,陈江华,王长希,李香铁,薛武军,林涛,彭龙开,谭建明,丰贵文,陈知水,韩文科,董隽,范昱,张小东*.中国活体肾移植患者急性排斥反应风险因素的多中心回顾性分析.中华医学杂志.2017.97(02).85-91.核心期刊 |
32. Qiang Zhang, Zexing Yu, Yue Xu, Song Zeng, Zijian Zhang, Wenrui Xue, Wei Wang, Xiaodong Zhang, XiaoPeng Hu*.Use of Contrast-Enhanced Ultrasonography to Evaluate Chronic Allograft Nephropathy in Rats and Correlations between Time-Intensity Curve Parameters and Allograft Fibrosis.Ultrasound in Medicine & Biology.2016.42(7).1574-1583.SCI |
33. Cameron AM, Wesson RN, Ahmadi AR, Singer AL, Hu X, Okabayashi T, Wang Y, Shigoka M, Fu Y, Gao W, Raccusen LC, Montgomery RA, Williams GM, Sun Z*.Chimeric Allografts Induced by Short-Term Treatment With Stem Cell Mobilizing Agents Result in Long-Term Kidney Transplant Survival Without Immunosuppression: II, Study in Miniature Swine.American Journal of Transplantation.2016.16(7).2066-2076.SCI |
34. Hu X, Okabayashi T, Cameron AM, Wang Y, Hisada M, Li J, Raccusen LC, Zheng Q, Montgomery RA, Williams GM, Sun Z*.Chimeric Allografts Induced by Short-Term Treatment With Stem Cell–Mobilizing Agents Result in Long-Term Kidney Transplant Survival Without Immunosuppression: A Study in Rats.American Journal of Transplantation.2016.16(7).2055-65.SCI |
35. 胡小鹏,薛文瑞,王伟,王勇,张小东*.膀胱癌根治术患者前列腺偶发癌的临床病理特点及其对预后的影响.中华泌尿外科杂志.2016.37(5).340-343.核心期刊 |
36. 尹航,徐岳#,张强,薛文瑞,张子健,曾嵩,胡小鹏*.术前单次高剂量ATG-F诱导治疗对肾移植受者的安全性及有效性.中华医学杂志.2016.96(22).1773-1777.核心期刊 |
37. Xue W, Zhang Q, Xu Y, Wang W, Zhang X, Hu X*.Effects of tacrolimus and cyclosporine treatment on metabolic syndrome and cardiovascular risk factors after renal transplantation.Chinses Medical Journal.2014.127(12).2376-81.SCI |
38. Hu X, Xue W, Zhang Q, Wang W, Zhang J, Zhang X.Effect of continuous hypothermic machine perfusion transport system (Airdrive(TM)) on canine kidney preservation.Chinses Medical Journal.2014.127(6).1105-09.SCI |
39. 胡小鹏,徐岳,张强.泌尿外科硕士研究生轮转策划对临床能力的影响.中国病案.2014.15(3).71-73.核心期刊 |
40. Hu X,Liu Y,Zhang X.The organ donation in China.Chinses Medical Journal.2012.125(21).3912-3913.SCI |
41. Hu X, Yin H, Zhang X. Evaluation and treatment of marginal grafts with surgical diseases in kidney transplantation. .Chinses Medical Journal.2012.125(3).461-464.SCI |
42. X. Hu, L. Ren, H. Yin, X. Zhang*.Signal Transducer and Activator of Transcription 1 and Matrix Metalloproteinase 3 Genetic Expression and Clinical Significance on Urothelial Tumors After Renal Transplantation.Transplantation Proceedings.2010.42(7).2534-2537.SCI |
43. 胡小鹏,任亮,尹航,杨晓勇,王玮,刘航,张小东*.转录信号传导子与激活子1和基质金属蛋白酶3在肾移植后尿路上皮肿瘤中的基因表达和临床意义.中华泌尿外科杂志.2010.31(10).687-690.核心期刊 |
44. hu xiaopeng, yin hang, liu hang, zhang xiaodong*.Rapamycin instead of mycophenolate mofetil or azathioprine in treatment of post-renal transplantation urothelial carcinoma.Chinses Medical Journal.2009.122(1).35-38.SCI |
45. 胡小鹏*,尹航,张小东.泌尿外科医师活体肾移植规范化培训.中国病案.2009.10(8).39-41.核心期刊 |
46. 胡小鹏*,尹航,张小东.55岁以上活体供肾移植中供受者肾功能的恢复特点.中华医学杂志.2009.89(38).2702-2704.核心期刊 |
47. 胡小鹏*,尹航,刘航,张小东.蛋白A免疫吸附联合利妥西单抗在PRA阳性肾移植受者中的应用七例报告.中华器官移植杂志.2009.30(9).548-551.核心期刊 |
48. 胡小鹏*,马麟麟,尹航,张小东.肾移植后发生尿路上皮肿瘤的患者转换西罗莫司治疗的临床观察.中华器官移植杂志.2008.29(10).620-622.核心期刊 |
49. 胡小鹏*,马麟麟,尹航,张小东.肾移植术后恶性肿瘤的临床分析.临床外科杂志.2006.14(8).504-505.核心期刊 |
50. 胡小鹏*,马麟麟,尹航,张小东.肾移植术后并发尿路上皮肿瘤的临床分析.中华泌尿外科杂志.2006.27(7).493-495.核心期刊 |